Panacea Biotec
Highly Engaged Employees
Manufacturing · India · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
B-1 Extn./ A-27, New Delhi, Nct, 110044,...Phone Number
+91 1141679000Website
www.panaceabiotec.comRevenue
$89.2 MillionStock Symbol
PANACEABIOIndustry
About Panacea Biotec
Panacea Biotec Org Chart
Is Panacea Biotec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Panacea Biotec
Funding: Get notified immidiatlly once Panacea Biotec has new funding data
Check out if Panacea Biotec is spiking on competitors!
Website visits: Recent activity has been detected on your website
Panacea Biotec, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Panacea Biotec had a recent Job posting/layoffs
Earning: See what the market has to say on Panacea Biotec recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Panacea Biotec launches new products
Check if Panacea Biotec has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Panacea Biotec is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Panacea Biotec is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Panacea Biotec.
Panacea Biotec Tech Stack
A closer look at the technologies used by Panacea Biotec
Most Recent Scoops
Panacea Biotec News & Media
Panacea Biotec Secures $4.75 Million Vaccine Supply Contract for 2026-2027 - ScanX
Panacea Biotec has secured a $4.75 million (~₹41 Crore) order for its Easyfive-TT vaccine from the Pan American Health Organization (PAHO). The contract, part of a Long-Term Agreement valid until December 31, 2027, covers supply for calendar years 2026 and 2027. Easyfive-TT is a pentavalent vaccine protecting against five diseases. This order strengthens Panacea Biotec's position in the international vaccine market, particularly in the Americas.Panacea Biotec Hits Highest Level In Over Three Years As Company Settles Patent Dispute ...
Shares of Panacea Biotec Ltd. hit the 5% upper circuit to touch the highest level in over three years on Tuesday as the company reached a settlement agreement with Sanofi Healthcare India Pvt. over a patent infringement claim related to a fully-liquid hexavalent vaccine.Panacea Biotec, Sanofi Settle Patent Dispute Over Hexavalent Vaccine - NDTV Profit
Panacea Biotec Ltd. announced on Monday that it has reached a settlement with Sanofi Healthcare India Pvt. over a patent infringement dispute related to a fully-liquid hexavalent vaccine. Both companies filed a joint application with the Delhi High Court, leading to the resolution of the case on Sept. 13, 2024, according to an exchange filing.Serum Institute of India sells 0.65% stake in Panacea Biotec, details here - CNBCTV18.com
Panacea Biotec has been drawing attention following a recent development where the Serum Institute of India sold a 0.65 percent stake in the company. Approximately four lakh shares were offloaded at a price of roughly Rs 140.65 per share.
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Panacea Biotec
Panacea Biotec is an innovation driven Biotechnology company doing research and development, manufacturing, sales, distribution and marketing of pharmaceuticals, vaccines and biosimilars. The company was founded in 1984 and is headquartered in New Delhi, India.... Read More